Therapeutic Monitoring of Plasma Digoxin for COVID-19 Patients Using a Simple UPLC-MS/MS Method

MLA

Qi Tangkai, et al. “Therapeutic Monitoring of Plasma Digoxin for COVID-19 Patients Using a Simple UPLC-MS/MS Method.” Current Pharmaceutical Analysis, vol. 17, Dec. 2021, pp. 1308–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........398c80294e1d994e34b7d2a59f760af7&authtype=sso&custid=ns315887.

APA

Qi Tangkai, Guo Mingquan, Li Yingying, Kong Ziqing, Zhang Lijun, Wang Lin, Yin Lin, Lu Hongzhou, Shi Huichun, Liu Pengyun, & Xing Yaru. (2021). Therapeutic Monitoring of Plasma Digoxin for COVID-19 Patients Using a Simple UPLC-MS/MS Method. Current Pharmaceutical Analysis, 17, 1308–1316.

Chicago

Qi Tangkai, Guo Mingquan, Li Yingying, Kong Ziqing, Zhang Lijun, Wang Lin, Yin Lin, et al. 2021. “Therapeutic Monitoring of Plasma Digoxin for COVID-19 Patients Using a Simple UPLC-MS/MS Method.” Current Pharmaceutical Analysis 17 (December): 1308–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........398c80294e1d994e34b7d2a59f760af7&authtype=sso&custid=ns315887.